The agreement provides Ultra Ultrasonik with the rights to sell in Turkey and includes minimum purchase requirements.
The SonaStar is used by neuro and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures.
Michael McManus, Jr, president and CEO of Misonix, said: “Misonix is pleased to welcome Ultra Ultrasonik to our growing distribution network in Europe and is excited about the market knowledge and demonstrated sales skills that they bring to the equation. We know the past successes of Ultra Ultrasonik’s ownership as distributors of advanced medical equipment in Turkey.”